Laguna Hills, CA, United States of America

Scott M Whitcup

This inventor holds 35 USPTO granted patents and 40 published patent applications, plus 5 CIPO patents and 20 EPO patents, primarily in Ocular Treatments. Top assignees: Allergan, Inc., Akrivista LLC, Allergen, Inc.. Active years: 2006-2025.

USPTO Granted Patents = 35 (Patent Applications = 40)

% Patents Active = 82.9

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 20 (Patent Applications = 28)

Average Co-Inventor Count = 3.6

ph-index = 10

Forward Citations = 314(Granted Patents)

Location History:

Laguna Hill, CA (US) (2014)
Laguna Hills, CA (US) (2006 - 2024)

Company Filing History:

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Dry Eye Syndrome

Ocular Conditions

Sustained Release

Retinopathy

Dermal Filler

Intraocular Drug Delivery

Botulinum Toxin

Nail Growth

Glaucoma Therapy

Prostaglandins

Chemotherapy Induced Loss

Neurological Disorders

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12220439 - Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye (2025-02-11),

2. 11903986 - Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye (2024-02-20),

3. 11622982 - Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye (2023-04-11),

4. 11078262 - High viscosity macromolecular compositions for treating ocular conditions (2021-08-03),

5. 10792345 - Dermal filler (2020-10-06),

6. 10682361 - Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction (2020-06-16),

7. 10363214 - Method for treating atrophic age related macular degeneration (2019-07-30),

8. 9622957 - Dermal filler (2017-04-18),

9. 9572859 - Compositions and methods for localized therapy of the eye (2017-02-21),

10. 9314425 - Ophthalmic compositions and methods for treating ophthalmic conditions (2016-04-19),

11. 9265775 - Pharmaceutical compositions (2016-02-23),

12. 9233071 - Methods for treating retinopathy with extended therapeutic effect (2016-01-12),

13. 9226931 - Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists (2016-01-05),

14. 9216183 - Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists (2015-12-22),

15. 9161970 - Dermal filler (2015-10-20),

Title: Scott M Whitcup - Innovator from Laguna Hills

Introduction: Scott M Whitcup is a renowned inventor based in Laguna Hills, California. He has made significant contributions to the field of innovation and holds several patents in his name.

Latest Patents: Scott M Whitcup has recently been granted patents for his groundbreaking inventions in the medical and healthcare industry. These patents showcase his dedication to improving people's lives through innovative solutions.

Career Highlights: With a successful career spanning several decades, Scott M Whitcup has worked with leading companies in the healthcare sector. His expertise and innovative mindset have led to the development of cutting-edge technologies that have revolutionized the industry.

Collaborations: Throughout his career, Scott M Whitcup has collaborated with top researchers, scientists, and engineers to bring his inventions to life. His ability to work in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Scott M Whitcup is a visionary inventor who continues to push the boundaries of innovation in the healthcare field. His passion for creating impactful solutions underscores his commitment to making a difference in the world.